Fabrice Egros

(Dr. Fabrice Egros Ph.D.)

Currently holds a position at Syndax Pharmaceuticals Inc

Positions

Position Company Period
Independent Director Syndax Pharmaceuticals Inc Sept. 1, 2013 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-11-19 2021-11-18
PS Planned sale
30 -0.2%
18.03
USD 541 		30 -0.2% 18.03 USD 541
2021-11-19 2021-11-18
PS Planned sale
14,000 -46.7%
18.03
USD 252,452 		14,000 -46.7% 18.03 USD 252,452
2021-08-20 2021-08-18
PS Planned sale
15,635 -49.4%
15.75
USD 246,328 		15,635 -49.4% 15.75 USD 246,328
2021-05-20 2021-05-18
PS Planned sale
1,683 -9.5%
18.65
USD 31,385 		1,683 -9.5% 18.65 USD 31,385
2021-05-20 2021-05-18
PS Planned sale
11,926 -40.3%
18.65
USD 222,398 		11,926 -40.3% 18.65 USD 222,398
2021-03-03 2021-03-01
PS Planned sale
74 -0.5%
24.31
USD 1,799 		74 -0.5% 24.31 USD 1,799
2021-03-03 2021-03-01
PS Planned sale
10,167 -38.7%
24.31
USD 247,182 		10,167 -38.7% 24.31 USD 247,182
// ... existing code ... // ... rest of the file ...